Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers

Radiation Research

Volumn 176, Issue 4, 2011, Pages 425-433

  Kunos, Charles A ^a   Ferris, Gina ^a   Pyatka, Natalie ^a   Pink, John ^a   Radivoyevitch, Tomas ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPICOLINALDEHYDE THIOSEMICARBAZONE; CASPASE 3; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE KINASE; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; HISTONE H2AX; RIBONUCLEOTIDE REDUCTASE; THYMIDINE KINASE 1;

ARTICLE; CELL DIVISION; CELL SURVIVAL; COLONY FORMATION; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPAIR; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RADIATION EXPOSURE; UTERINE CERVIX CANCER;

CULTURE MEDIA; DEOXYRIBONUCLEOSIDES; DEOXYRIBONUCLEOTIDES; DNA REPAIR; ENZYME INHIBITORS; FEMALE; HUMANS; OXIDATION-REDUCTION; PYRIDINES; RADIATION TOLERANCE; RIBONUCLEOTIDE REDUCTASES; THIOSEMICARBAZONES; UTERINE CERVICAL NEOPLASMS;

EID: 80053236914     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2556.1     Document Type: Article

References (28)

1. Hakansson P, Hofer A, Thelander L. Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells. J Biol Chem 2006; 281:7834-41. (Pubitemid 43847398)
2. Sandrini M, Piskur J. Deoxyribonucleoside kinases: two enzyme families catalyze the same reaction. Trends Biochem Sci 2005; 30:225-8. (Pubitemid 40693862)
3. Reichard P. Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem 1988; 57:349-74.
4. Chang E, Shiu A, Mendel E, Mathews L, Mahajan A, Allen P, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 2007; 7:151-60. (Pubitemid 47219748)
5. Eklund H, Uhlin U, Farnegardh M, Logan DT, Nordlund P. Structure and function of the radical enzyme ribonucleotide reductase. Prog Biophys Mol Biol 2001; 77:177-268. (Pubitemid 34131599)
6. Kolberg M, Strand KR, Graff P, Andersson KK. Structure, function, and mechanism of ribonucleotide reductases. Biochim Biophys Acta 2004; 1699:1-34. (Pubitemid 38680791)
7. Chabes A, Thelander L. Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks. J Biol Chem 2000; 275:17747-53. (Pubitemid 30430824)
8. Suzuki C, Jacobson H, Hatschek T, Torkzad M, Boden K, Eriksson-Alm Y, et al. Radiologic measurements of tumor response to treatment: Practical approaches and limitations. Radiographics 2008; 28:329-44.
9. Xue L, Zhou B, Liu X, Qiu W, Jin Z, Yen Y. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Cancer Res 2003; 63:980-6. (Pubitemid 36278428)
10. Zhou B, Liu X, Mo X, Xue L, Darwish D, Qiu W, et al. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53. Cancer Res 2003; 63:6583-94. (Pubitemid 37322936)
11. Kuo ML, Kinsella T. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells. Cancer Res 1998; 58:2245-52. (Pubitemid 28232915)
12. Kunos C, Chiu S, Pink J, Kinsella T. Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein. Radiat Res 2009; 172:666-76.
13. Csapo Z, Keszler G, Safrany G, Spasokoukotskaja T, Talianidis I, Staub M, et al. Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes. Biochem Pharmacol 2003; 65:2031-9. (Pubitemid 36629587)
14. Boothman D, Davis T, Sahijdak W. Enhanced expression of thymidine kinase in human cells following ionizing radiation. Int J Radiat Oncol Biol Phys 1994; 30:391-8. (Pubitemid 24309742)
15. Eriksson S, Munch-Petersen B, Johansson K, Eklund H. Structure and function of cellular deoxyribonucleoside kinases. Cell Mol Life Sci 2002; 59:1327-46.
16. Fujiwaki R, Hata K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, et al. Clinical value of thymidine kinase in patients with cervical carcinoma. Oncology 2001; 61:47-54. (Pubitemid 32727587)
17. Belt J, Marina N, Phelps C, Crawford C. Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul 1993; 33:235-52. (Pubitemid 223051922)
18. Crook T, Wrede D, Vousden K. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 1991; 6:873-5. (Pubitemid 21924163)
19. Patillo R, Hussa R, Story M, Ruckert A, Shalaby M, Mattingly R. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 1977; 196:1456-8. (Pubitemid 8122337)
20. Kunos C, Radivoyevitch T, Pink J, Chiu S, Stefan T, Jaccobberger J, et al. Ribonucleotide reductase inhibition enhances chemoradio-sensitivityof human cervical cancers. Radiat Res 2010; 174:574-81.
21. Kunos C, Waggoner S, Von Gruenigen V, Eldermire E, Pink J, Dowlati A, et al. Phase I trial of intravenous 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in combination with pelvic radiation therapy and weekly cisplatin chemotherapy for locally advanced cervical cancer. Clin Cancer Res 2010; 16:1298-306.
22. Radivoyevitch T, Taverna P, Schupp J, Kinsella TJ. The linear-quadratic log-survival radiation dose response model: Confidence ellipses, drug-drug interactions, and brachytherapeutic gains. Med Hypotheses Res 2004; 1:23-8.
23. Lindstrom MJ, Kunugi KA, Kinsella TJ. Global comparison of radiation and chemotherapy dose-response curves with a test for interaction. Radiat Res 1993; 135:269-77. (Pubitemid 23283805)
24. Molina-Arcas M, Casado F, Pastor-Anglada M. Nucleoside transporter proteins. Curr Vasc Pharmacol 2009; 7:426-34.
25. Ritzel M, Ng A, Yao S, Graham K, Lowewen S, Smith K, et al. Recent molecular advances in studies of the concentrative NAz-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). Mol Membr Biol 2001; 18:65-72. (Pubitemid 32521598)
26. Sternberg C, Whelan P, Hetherington J, Paluchowska B, Slee P, Vekemans K, et al. Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer. Oncology 2005; 68:2-9. (Pubitemid 40675002)
27. Pontarin G, Fijolek A, Pizzo P, Ferraro P, Rampazzo C, Pozzan T, et al. Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Proc Natl Acad Sci USA 2008; 105:17801-6.
28. Niida H, Katsuno Y, Sengoku M, Shimada M, Yukawa M, Ikura M, et al. Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase. Genes Dev 2010; 24:333-8.